ICON Return on Investment 2010-2023 | ICLR
Current and historical return on investment (ROI) values for ICON (ICLR) over the last 10 years.
| ICON ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2023-12-31 | $0.96B | $12.91B | 7.38% |
| 2023-09-30 | $0.89B | $12.87B | 6.87% |
| 2023-06-30 | $0.87B | $13.00B | 6.70% |
| 2023-03-31 | $0.84B | $13.01B | 6.44% |
| 2022-12-31 | $0.80B | $13.10B | 6.07% |
| 2022-09-30 | $0.74B | $13.03B | 5.59% |
| 2022-06-30 | $0.50B | $13.14B | 3.72% |
| 2022-03-31 | $0.43B | $13.16B | 4.04% |
| 2021-12-31 | $0.38B | $13.45B | 4.74% |
| 2021-09-30 | $0.35B | $13.84B | 6.84% |
| 2021-06-30 | $0.46B | $2.38B | 26.65% |
| 2021-03-31 | $0.40B | $2.28B | 35.79% |
| 2020-12-31 | $0.39B | $2.20B | 71.12% |
| 2020-09-30 | $0.39B | inf% | |
| 2020-06-30 | $0.39B | 82.25% | |
| 2020-03-31 | $0.44B | 46.43% | |
| 2019-12-31 | $0.43B | 31.28% | |
| 2019-09-30 | $0.42B | $1.89B | 23.20% |
| 2019-06-30 | $0.41B | $1.88B | 23.19% |
| 2019-03-31 | $0.38B | $1.77B | 22.76% |
| 2018-12-31 | $0.37B | $1.70B | 22.91% |
| 2018-09-30 | $0.36B | $1.68B | 22.75% |
| 2018-06-30 | $0.35B | $1.59B | 22.67% |
| 2018-03-31 | $0.35B | $1.55B | 23.20% |
| 2017-12-31 | $0.34B | $1.54B | 23.84% |
| 2017-09-30 | $0.33B | $1.48B | 24.55% |
| 2017-06-30 | $0.33B | $1.38B | 24.34% |
| 2017-03-31 | $0.32B | $1.29B | 24.59% |
| 2016-12-31 | $0.31B | $1.29B | 24.29% |
| 2016-09-30 | $0.30B | $1.39B | 24.38% |
| 2016-06-30 | $0.30B | $1.26B | 33.25% |
| 2016-03-31 | $0.29B | $1.19B | 50.37% |
| 2015-12-31 | $0.28B | $1.11B | 101.17% |
| 2015-09-30 | $0.26B | inf% | |
| 2015-06-30 | $0.25B | inf% | |
| 2015-03-31 | $0.23B | inf% | |
| 2014-12-31 | $0.20B | inf% | |
| 2014-09-30 | $0.18B | inf% | |
| 2014-06-30 | $0.15B | inf% | |
| 2014-03-31 | $0.14B | inf% | |
| 2013-12-31 | $0.22B | inf% | |
| 2013-09-30 | $0.21B | inf% | |
| 2013-06-30 | $0.20B | inf% | |
| 2013-03-31 | $0.19B | inf% | |
| 2012-12-31 | $0.16B | inf% | |
| 2012-09-30 | $0.15B | inf% | |
| 2012-06-30 | $0.13B | inf% | |
| 2012-03-31 | $0.13B | inf% | |
| 2011-12-31 | $0.12B | inf% | |
| 2011-09-30 | $0.22B | inf% | |
| 2011-06-30 | $0.24B | inf% | |
| 2011-03-31 | $0.25B | inf% | |
| 2010-12-31 | $0.18B | inf% | |
| 2010-09-30 | $0.10B | inf% | |
| 2010-06-30 | $0.11B | 79.72% | |
| 2010-03-31 | $0.12B | 41.95% | |
| 2009-12-31 | $0.12B | 28.28% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $24.578B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.697B | 15.52 |
| Cencora (COR) | United States | $47.247B | 18.86 |
| DiDi Global (DIDIY) | China | $22.930B | 0.00 |
| Avantor (AVTR) | United States | $16.557B | 22.81 |
| CochLear (CHEOY) | $13.675B | 0.00 | |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| Revvity (RVTY) | United States | $12.448B | 21.67 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.029B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.979B | 21.84 |
| Medpace Holdings (MEDP) | United States | $11.658B | 38.35 |
| Solventum (SOLV) | United States | $10.708B | 0.00 |
| Natera (NTRA) | United States | $10.700B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.966B | 52.04 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.625B | 34.43 |
| Organon (OGN) | United States | $4.601B | 4.46 |
| PACS (PACS) | United States | $3.460B | 0.00 |
| Progyny (PGNY) | United States | $3.177B | 53.32 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| Surgery Partners (SGRY) | United States | $3.044B | 28.28 |
| Life Times (LTH) | United States | $2.774B | 30.65 |
| GoodRx Holdings (GDRX) | United States | $2.631B | 133.20 |
| Premier (PINC) | United States | $2.522B | 9.23 |
| Teladoc Health (TDOC) | United States | $2.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.141B | 6.93 |
| Agilon Health (AGL) | United States | $2.121B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.816B | 0.00 |
| Agiliti (AGTI) | United States | $1.368B | 22.33 |
| Establishment Labs Holdings (ESTA) | $1.325B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.273B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.947B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.617B | 4.08 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.518B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.64 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 0.00 |
| CareDx (CDNA) | United States | $0.423B | 0.00 |
| LifeMD (LFMD) | United States | $0.404B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.395B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| MultiPlan (MPLN) | United States | $0.356B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 4.14 |
| GeneDx Holdings (WGS) | United States | $0.271B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| So-Young (SY) | China | $0.131B | 44.00 |
| Biodesix (BDSX) | United States | $0.125B | 0.00 |
| Oncology Institute (TOI) | United States | $0.084B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |